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Abstract Low-molecular-weight heparins have become
the predominant choice for deep venous thrombosis pro-
phylaxis and treatment. However, their use may cause
bleeding complications. Intrahepatic bleeding is excep-
tional and only very few cases have been described. The
authors present a unique case of fatal intrahepatic hema-
toma complicating nadroparin use in a 65-year-old woman
with a hepatic cyst who was admitted to hospital for uni-
lateral total hip arthroplasty. At autopsy, hemoperitoneum
(2,000 ml of blood and clots) was evident. A ruptured sub-
capsular hematoma involving the right lobe of the liver was
observed. The hemorrhage within the cyst induced by the
nadroparin use was likely responsible for the subsequent
hepatic hematoma, liver rupture, and death. This case
highlights the need for pathologists and surgeons to be
aware of the possibility of intrahepatic hematoma in
patients who have received low-molecular-weight hepa-
rins, undergone major surgery and present postoperative
hemodynamic instability, especially in those with preop-
erative diagnosis of hepatic cyst.
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Introduction
Low-molecular-weight heparins (LMWHs) are prepared by
the enzymatic or chemical depolymerization of standard
heparin and have become the predominant choice as first line
agents for both deep venous thrombosis (DVT) prophylaxis
and treatment. However, LMWH use has been shown to
increase bleeding complications [1, 2]. Documented risk
factors for LMWH-induced hemorrhage include advanced
age, concurrent anti-platelet therapy, high doses, concomi-
tant thrombocytopenia, and impaired renal function [1–4].
LMWH-associated hemorrhages in the absence of any
trauma range from lower extremity, abdominal wall, and
retroperitoneal hematomas to spontaneous splenic rupture
[1, 5, 6]. Spontaneous intrahepatic bleeding is exceptional
and only very few cases have been described [7]. Here we
present a unique case of fatal intrahepatic hematoma and
subsequent spontaneous bleeding from the liver surface
complicating nadroparin use in a patient with a hepatic cyst.
Case history
A 65-year-old Caucasian woman diagnosed as having
osteoarthritis of the right hip was admitted to hospital for
unilateral total hip arthroplasty. Her past medical history
was significant for hypertension and tobacco smoking. She
did not have a history of any bleeding disorders, coagulop-
athies, thrombocytopenia, or diabetes and had never
received anticoagulant or anti-platelet medication. All lab-
oratory results were unremarkable during preoperative
assessment. The liver was enlarged and a hepatic cyst of the
anterior part of the right lobe (diameter 2.8 cm) was detected
by ultrasound. Preoperatively and postoperatively the
patient received nadroparin calcium by subcutaneous
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injection starting 12 h before surgery at 0.4 ml (3,800 IU)
per day. The patient was discharged 3 days later in stable
condition with normal laboratory values. On postoperative
day 9 the patient complained of severe abdominal pain and
developed abdominal distention, hypotension, and tachy-
cardia. She was admitted to the intensive care unit and
immediately transfused. There was no apparent source of
bleeding at the surgical site. However, in view of the
abdominal distension, a bedside ultrasound was performed
demonstrating free fluid in the abdomen mostly around the
perihepatic area. Her medical status continued to deteriorate
despite supportive care and she went into shock. Attempted
manual cardiopulmonary resuscitation was unsuccessful and
the patient died before laparotomy could be performed.
Postmortem examination was requested by the inquiring
authorities. Fresh injection marks due to medical inter-
vention were observed on the upper limbs. At autopsy, no
rib or sternum fractures were observed. The pericardial sac
was unremarkable with no contusions, effusions or adhe-
sions. No hemorrhages or contusions of the epicardium
were found. The heart weighed 315 g and did not reveal
any hypertrophy or dilatation. The myocardium did not
exhibit fibrosis or ischemic areas. No lacerations or hem-
orrhages of the cardiac ventricles were observed. The
coronary arteries had a normal anatomic course and
revealed mild atheromatous disease without significant
stenosis. The mediastinum and the thoracic aorta were
unremarkable, with no bruising of the wall. The lungs were
relatively edematous, with no pulmonary contusions.
Examination of the abdominal cavity showed hemoperito-
neum (2,000 ml of blood and clots). A ruptured sub-cap-
sular hematoma involving the anterior and central parts of
the right lobe of the liver was observed (Fig. 1). Minute
remnants of the cyst detected by ultrasound were identified
within the hematoma. The spleen and kidneys did not show
any significant, macroscopic changes. Retroperitoneal
bleeding was not observed. The omentum and small bowel
did not show any abnormality. No hemorrhage was noted at
the surgical site. The brain weighed 1,050 g and was
macroscopically unremarkable. Sections of most organs
were examined microscopically. Histology revealed areas
of fatty degeneration of the liver and confirmed the pre-
sence of a hemorrhagic, simple cyst of the right lobe. Areas
of pulmonary emphysema and hyalinized glomeruli in the
kidneys were also observed. Toxicology and bacteriology
was unremarkable. Biochemistry failed to reveal results
consistent with liver dysfunction.
Discussion
Deep venous thrombosis is a common, serious complica-
tion after major orthopedic surgery of the lower extremi-
ties. Because of the high risk of DVT and its considerable
morbidity and mortality after abdominal and major ortho-
pedic surgical procedures, the routine use of DVT-pro-
phylaxis is recommended for all patients undergoing hip
and knee arthroplasty [2, 8].
Heparin is usually given in low doses by subcutaneous
injection to prevent venous thrombosis (prophylactic hep-
arin), in higher doses to treat patients with acute venous
thromboembolism or with acute coronary syndromes
(therapeutic heparin), and in very high doses in patients
during open heart surgery [3].
Bleeding is the major complication associated with the
use of any type of anticoagulant and thrombolytic therapy
and may occur at the injection or instrumentation sites or
any remote areas not directly involved with the surgery [2,
3, 7]. Comorbid conditions, particularly recent surgery or
trauma, are important risk factors for heparin-induced
bleeding. Concomitant anti-platelet medication, thrombo-
lytic therapy, renal failure, and patient age have also been
implicated as having a role in hemorrhage subsequent
anticoagulant treatment [4].
Hemorrhages associated with anticoagulant use have
included abdominal wall hematoma (i.e. rectus muscle
sheath hematoma), retroperitoneal hematoma, intrahepatic
hemorrhage, spleen rupture, spinal, or epidural hematoma
as well as unilateral or bilateral lower extremity hematoma
[1, 5, 6, 9–11].
Spontaneous splenic rupture has been reported in asso-
ciation with thrombolytic agents, unfractionated heparin,
and LMWHs [9, 12].
Spontaneous retroperitoneal hematomas have been
described after warfarin and heparin anticoagulation [5, 6,
10, 11, 13–15]. Despite the low incidence of severe
Fig. 1 The hematoma involving the anterior and central parts of the
right lobe of the liver
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hemorrhage associated with LMWH use, these drugs carry
the risk of potentially deadly adverse effects and rare, fatal
cases of retroperitoneal hematomas have been observed
following anticoagulation with LMWHs [5, 13, 14].
Spontaneous intrahepatic hematomas and hepatic rup-
ture of previously normal livers associated with warfarin,
heparin or LMWHs therapy are extraordinary, with no fatal
cases reported in the literature [7, 16–19]. Houde and
Steinberg [7] reported the case of an 86-year-old woman
who was admitted for total hip arthroplasty for osteoar-
thritis of the right hip. Postoperatively the patients received
enoxaparin 30 mg by subcutaneous injection twice a day
starting 12 h after surgery. An intra-hepatic hemorrhage
with no capsular rupture was diagnosed on the 3rd post-
operative day. Iriz et al. [16] reported the case of a 64-year-
old woman who underwent aortic valve replacement due to
aortic stenosis. LMWH was not given preoperatively.
Dalteparin (10,000 IU/day) was prescribed at the 12th
postoperative hour. Free intra-abdominal hemorrhage from
a vein near the falciform ligament of the liver and from a
bleeding laceration of the splenic capsule occurred on the
2nd postoperative day. More recently, Mir et al. [20]
reported the case of a 58-year-old male who was admitted
for mitral valve repair due to valve regurgitation. A mas-
sive sub-capsular hematoma involving both lobes of the
liver and active bleeding was diagnosed 8 h postopera-
tively, though the authors did not find a clear association
between anticoagulant medication and intra-hepatic
hematoma.
LMWHs, including nadroparin, have proven to be as
safe and effective as unfractionated heparin for the pro-
phylaxis of DVT in abdominal, hip and knee replacement
surgery, with added advantages of decreased laboratory test
value monitoring and outpatient drug administration [5, 7,
13].
Data obtained from meta-analyses and clinical trials
comparing LMWH with unfractionated heparin treatment
support the inference that LMWH does not result in an
increased risk of major bleeding compared with unfrac-
tionated heparin [3].
Simple hepatic cyst is a biliary malformation, which does
not have communication with the intrahepatic biliary tree.
Most cysts measure less than 3 cm and are asymptomatic.
Microscopically, they are lined by a single layer of cuboid or
columnar epithelial cells, resembling biliary epithelial cells.
In the majority of patients, liver function tests are within the
normal range. Asymptomatic, single liver cysts, even when
large, do not require treatment or surveillance. However,
treatment may be needed if cyst growth leads to symptoms
such as abdominal pain, abdominal distension, early satiety,
or compression of adjacent structures. Indeed, the cells lin-
ing the cavity of hepatic cysts secrete the fluid that causes the
cyst to enlarge [21, 22].
In the case herein described, the hemorrhage within the
hepatic cyst induced by the subcutaneous use of nadroparin
was likely responsible for the subsequent hepatic hematoma,
liver rupture and death. This sequence of events is even more
extraordinary considering that spontaneous hemorrhages of
simple hepatic cysts rarely occur [20]. Visceral injury fol-
lowing cardiopulmonary resuscitation (external cardiac
massage) has been frequently described in the literature,
including cardiac, hepatic, splenic, and mesenteric lacera-
tions. Rare cases of hemoperitoneum have also been repor-
ted [23]. In the case reported here, a bedside ultrasound
demonstrated the presence of free fluid in the abdomen,
mostly around the perihepatic area. Additionally, no frac-
tures of the ribs or sternum were observed at autopsy. The
epicardium, myocardium, mediastinum, lungs, aorta, and
spleen were unremarkable and did not reveal contusions or
lacerations. All these findings tend to exclude the possibility
that the hemorrhage within the cyst and the ruptured
hematoma of the liver might have been complications of the
cardiopulmonary resuscitation and support the hypothesis of
a spontaneous intrahepatic hemorrhage.
Key points
1. Bleeding is the major complication of anticoagulant
therapy.
2. Spontaneous intra-hepatic hematoma is an exceptional
but potentially lethal condition.
3. Spontaneous retroperitoneal hemorrhage, spleen rup-
ture and spontaneous intra-hepatic hematoma may
occur in patients who receive preoperatively and/or
postoperatively therapeutic doses of anticoagulants.
4. Surgeons and pathologists must always be aware of the
possibility of intra-abdominal bleeding from the liver
in patients who have received LMWHs, undergone
major surgery and present postoperative hemodynamic
instability, especially in those with preoperative diag-
nosis of hepatic cyst.
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